Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 2
2016 1
2020 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, Schinagl D, Oei B, Rodenhuis C, Horiot JC, Struikmans H, Van Limbergen E, Kirova Y, Elkhuizen P, Bongartz R, Miralbell R, Morgan D, Dubois JB, Remouchamps V, Mirimanoff RO, Collette S, Collette L; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Bartelink H, et al. Lancet Oncol. 2015 Jan;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. Epub 2014 Dec 9. Lancet Oncol. 2015. PMID: 25500422 Clinical Trial.
[Radiation-related heart toxicity: Update in women].
Marlière S, Vautrin E, Saunier C, Chaikh A, Gabelle-Flandin I. Marlière S, et al. Among authors: gabelle flandin i. Ann Cardiol Angeiol (Paris). 2016 Dec;65(6):411-419. doi: 10.1016/j.ancard.2016.10.012. Epub 2016 Nov 11. Ann Cardiol Angeiol (Paris). 2016. PMID: 27842711 Review. French.
Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial.
To NH, Gabelle-Flandin I, Luong TMH, Loganadane G, Ouidir N, Boukhobza C, Grellier N, Verry C, Thiolat A, Cohen JL, Radosevic-Robin N, Belkacemi Y. To NH, et al. Among authors: gabelle flandin i. Cancers (Basel). 2023 Mar 29;15(7):2030. doi: 10.3390/cancers15072030. Cancers (Basel). 2023. PMID: 37046691 Free PMC article.
[The impact of radiation therapy on sexual function].
Leroy T, Gabelle Flandin I, Habold D, Hannoun-Lévi JM. Leroy T, et al. Among authors: gabelle flandin i. Cancer Radiother. 2012 Sep;16(5-6):377-85. doi: 10.1016/j.canrad.2012.05.012. Epub 2012 Aug 23. Cancer Radiother. 2012. PMID: 22921960 Review. French.
Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials.
To NH, Kossai M, Ouidir N, Grellier N, Assaf E, Gabelle-Flandin I, Belkacemi Y, Radosevic-Robin N. To NH, et al. Among authors: gabelle flandin i. Rep Pract Oncol Radiother. 2022 Dec 29;27(6):1114-1118. doi: 10.5603/RPOR.a2022.0112. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36632297 Free PMC article. No abstract available.
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial.
Le Bras A, Belkacemi Y, Bourgier C, Gabelle-Flandin I, Petit A, Guilbert P, Geffrelot J, Racadot S, Rivin Del Campo E, Hanzen C, Charra Brunaud C, Auzac G, Lacornerie T, Lemonnier J, Lartigau E, Durand-Zaleski I. Le Bras A, et al. Among authors: gabelle flandin i. Radiother Oncol. 2023 Oct;187:109818. doi: 10.1016/j.radonc.2023.109818. Epub 2023 Jul 20. Radiother Oncol. 2023. PMID: 37480995 Clinical Trial.
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.
11 results